Contact

Point us to a document

This journal reads what regulators, labels and review panels wrote and sets it against what a marketing claim says. If a label, a revision or a review panel report deserves a line-by-line reading, use the form on this page to point us to it. Name the document and the revision you read.

Where we read the paperwork

The journal reads documents in four areas. One is menopause hormone therapy labeling, including the boxed warning removal. Another is bioidentical hormones for women, alongside the National Academies review of compounded hormone therapy. The third is peptide therapy, where we also follow the FDA's eased compounded peptide restrictions. The last is hypothyroidism diagnosis, treatment and monitoring.

Outside reading

Two outside pages sit near this journal's subject matter: UPMC HealthBeat on choosing a clinical aesthetics provider and the American Society for Dermatologic Surgery's medical spa safety resources. Each is worth reading in full at the source.